After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Prescription drugs designed by AI could be in clinical trials within years, DeepMind's CEO predicted. Demis Hassabis said in an interview he'd be "disappointed" if it took more than a couple of years.

AI that is as powerful as the human brain could arrive within the next few years, according to the boss of Google-owned AI lab DeepMind. The Wall Street Journal reported the news .

Tech giant Google and its subsidiary AI research lab, DeepMind, have created a basic human-to-robot translator of sorts. They describe it as a “first-of-its-kind vision-language-action model.” ...

Google LLC’s artificial intelligence research unit DeepMind today unveiled a trio of new advances that it says will help robots make better, faster and safer decisions in the wild.. The advances ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes ...